RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Earnings per share

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndEarnings per share (USD)YoY (%)
Dec 31, 20247+202.16%
Dec 31, 20232.3-6.10%
Dec 31, 20222.5+2.07%
Dec 31, 20212.4+82.58%
Dec 31, 20201.3-73.76%
Dec 31, 20195+45.80%
Dec 31, 20183.5+24.55%
Dec 31, 20172.8+3.75%
Dec 31, 20162.7+16.09%
Dec 31, 20152.3-69.82%
Dec 31, 20147.6+117.09%
Dec 31, 20133.5+37.65%
Dec 31, 20122.6+23.19%
Dec 31, 20112.1+7.81%
Dec 31, 20101.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)